Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study

MLA

Yunhong Wu, et al. Safety and Immunogenicity of COVID-19 Vaccination in Patients with Non-Alcoholic Fatty Liver Disease (CHESS2101): A Multicenter Study. Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7d96adcf71833b3552431af4d3c56367&authtype=sso&custid=ns315887.

APA

Yunhong Wu, Ye Gu, Shiying Yang, Yan Yan, Shengqiang Zou, Jiansong Ji, Qing Xie, Shiqi Diao, Fenxiang Li, Tao Ren, Fengxian Wang, Jianxin Liu, Aiguo Zhang, Guohong Ge, Jonathan A. Fallowfield, Xing Liu, Fazong Wu, Shiliang Zhang, Xiaolong Qi, … Yifei Huang. (2021). Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study.

Chicago

Yunhong Wu, Ye Gu, Shiying Yang, Yan Yan, Shengqiang Zou, Jiansong Ji, Qing Xie, et al. 2021. “Safety and Immunogenicity of COVID-19 Vaccination in Patients with Non-Alcoholic Fatty Liver Disease (CHESS2101): A Multicenter Study,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7d96adcf71833b3552431af4d3c56367&authtype=sso&custid=ns315887.